Biopharmaceuticals.
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B Pricing Reform; Issue relating to Home infusion under Medicare FFS; H.R.5547/S.476 - Maintaining Investments in New Innovation Act.
MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
JOHN MICHAEL GONZALEZ COREY MALMGREN TIMOTHY ROBINSON JONATHON JONES BRYANT HALL JOHN KIRKLAND TWOMEY DANIEL HOWARD ZAWITOSKI